LeafCann is pleased to announce it has signed a non-exclusive distribution agreement with Health House International Pty Ltd.
Health House International Pty Ltd. Is an Australian-based pharmaceutical wholesaler, specialising in the distribution of medicinal cannabis. This agreement will strengthen LeafCann’s sales pipeline for both medicinal cannabis and its non-cannabis botanical extract ranges.
Providing quality medicine
The move will enable LeafCann to reach more pharmacies and provide patients with high quality, Good Manufacturing Practice (GMP) certified medicinal cannabis products and comes on the back of a wholesale dealers and import licence that enables LeafCann to import, warehouse and distribute a range of cannabis medicines under the Australian Government’s Special Access and Authorised Prescriber schemes.
LeafCann Chair, Ilario Faenza, said: “This agreement is another win for the company and brings us a step closer to filling the void in the current market which needs reliable, high-quality, affordable medicinal cannabis. Our goal has always been to provide Australian patients with the best available medicine and this agreement helps us to do that.
“LeafCann has teamed up with the ideal supplier of EU GMP certified organic medicinal cannabis in The Green Organic Dutchman (TGOD) and now we have the mechanism to provide these products to pharmacies and reach more patients through Health House International’s extensive distribution network.”
LeafCann expects to have medicinal cannabis products available in the first half of 2021, with its non-cannabis, terpene-based range – Cephyra Activated Oils – expected to come to market also during the first half.
